By
Cianna GreavesSasha-Ann Simons
[month] [day], [year], [hour]:[minute][ampm] [timezone]
- SHARE
- COPY LINK
Weight loss drugs like Ozempic and Wegovy are one of the fastest-growing pharmaceuticals
Since 2024 the number of U.S. adults on GLP-1 medications has nearly quadrupled and doesn’t show signs of letting up
Beyond weight loss, the drug designed to help control Type 2 Diabetes has other health benefits, that include reduced risk of cardiovascular disease and helping with sleep disorders
But as newer GLP-1 medications hit the market, questions remain about side effects, health equity and the cultural impact
On today’s in the Loop, what have we learned so far about the popular drug? And how have GLP-1s changed how we think about health and weight loss? Our panel of experts dig into the how, why and what’s next for weight loss drugs
GUESTS:Dr. Michah Eimer, clinical assistant professor of medicine in the division of cardiology at Northwestern University Feinberg SchoolDavid D. Kim, PhD, Assistant Professor of Medicine and Public Health Sciences at University of ChicagoRachelle Lacroix Mallick, registered dietician and nutritionist with a focus on reproductive health
